Alexza Pharmaceuticals, Inc. (ALXA) Posts Q3 GAAP Loss of 19c/Share

Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q3 GAAP loss of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $670 thousand.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Reading (RDI) Tops Q2 EPS by 4c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c